Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial
- Conditions
- Circumferential Resection MarginDisease-free SurvivalOveral SurvivalIntraoperative Perforation of RectumLocal Recurrence of Malignant Tumor of Rectum
- Interventions
- Other: neoadjuvant chemoradiotherapy
- Registration Number
- NCT03504449
- Lead Sponsor
- Beijing Chao Yang Hospital
- Brief Summary
For now, neoadjuvant chemoradiotherapy is routinely performed for T3N1-2M0 rectal cancer. However, there are lots of complications following neoadjuvant chemoradiotherapy, such as Wound-related complications, anastomotic leakage, anastomotic stenosis, sexual dysfunction, testicular or ovary failure. Patients undergoing resection for rectal cancer had low rates of local recurrence and long disease-free survival regardless of whether an APR, CAA or low AR was performed. The main purpose of preoperative radiotherapy is to lower the local recurrence. For the T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, we suppose might not necessary to receive neoadjuvant chemoradiotherapy, for operation can achieve the negative circumferential resection margin.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 350
- Tumor within 12 cm of the anal verge
- T3N1-2 as determined by preoperative MRI examination
- negative circumferential resection margin determined by preoperative MRI examination
- Absence of distant metastases
- Absence of intestinal obstruction
- With distant metastases
- With intestinal obstruction
- Pregnancy or lactation
- With operation contraindication
- With mental disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description surgery with neoadjuvant chemoradiotherapy neoadjuvant chemoradiotherapy For T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, recieve surgery following neoadjuvant chemoradiotherapy. surgery without neoadjuvant chemoradiotherapy neoadjuvant chemoradiotherapy For T3N1-2M0 rectal cancer with negative circumferential resection margin based on MRI assessment, recieve surgery without neoadjuvant chemoradiotherapy.
- Primary Outcome Measures
Name Time Method circumferential resection margin one week after operation introperative perforation During the operation
- Secondary Outcome Measures
Name Time Method local recurrece 3 years after operation overal survival 3 years after operation disease-free survival 3 years after operation complications 30 days after operation
Trial Locations
- Locations (1)
Beijing Chaoyang Hospital
🇨🇳Beijing, Beijing, China